Tallahassee, FL 10/31/11 (StreetBeat) --Nps Pharmaceuticals Inc. (Nasdaq: NPSP), a maker of drugs for gastrointestinal illnesses, plunged as much as 38 percent after saying three people in a clinical trial for its Gattex drug got cancer and two of them died. The shares are currently down $2.67, trading at $5.09 per share. Shares of DreamWorks Animation SKG (Nasdaq: DWA) fell 10% Monday after the company's latest theatrical film, "Puss In Boots," turned in the worst opening weekend for a DreamWorks movie since "Antz" in 1998. The film earned $34 million at the U.S. box office. Cowen & Co. analyst Doug Creutz wrote to client that the film's underperformance "is further evidence that increasing competition in the animated film space has significantly degraded the domestic box office otential for individual animated films." Creutz, who rates DreamWorks Animation neutral, noted that this is the fifth of the studio's films in a row to open to lackluster business "despite generally positive reviews."
Loews Corp's (NYSE: L) third-quarter earnings surged as its CNA Financial Corp. insurance unit swung to the black. But shares dropped 2.4% as the conglomerate's earnings results fell short of analysts' expectations. It is currently trading at $40.46 per share.
StreetBeat DIsclaimer
No comments:
Post a Comment